Charges Filed Against Chinese Companies and Nationals for Fentanyl Precursors

Two pharmaceutical companies from China and six Chinese individuals have been indicted for smuggling chemicals used to manufacture fentanyl into the U.S. According to FBI Director Kash Patel, this indictment follows a federal investigation in Ohio, known as Operation Boxcutter, which uncovered a collaboration between these Chinese firms and Mexico’s Gulf Cartel.

A grand jury in Dayton, Ohio, issued the indictment on Tuesday against Shandong Believe Chemical Company and Shandong Lanhan Biotechnology Chemical and Pharmaceutical Company. The charges state that both companies actively marketed, sold, and exported precursor substances to the U.S. and other nations specifically for the production and distribution of fentanyl to drug traffickers, including the Gulf Cartel, which was explicitly mentioned in the indictment.

The indictment claims that these companies marketed the animal tranquilizer medetomidine, selling it directly to traffickers such as the Gulf Cartel. The purpose of medetomidine, as alleged, was to serve as a cutting agent to enhance fentanyl yields while maintaining its potency.

The six individuals identified in the indictment are Hansong Chao, Gao Yanpeng, Xia Yi, Zhang Jiang, Wang Zoran, and Zhang Chunhai, implicated in the conspiracy. Patel highlighted the significance of the indictments through a social media post, noting an unprecedented level of cooperation with China’s Ministry of Public Security (MPS) during the investigation.

Patel mentioned that the MPS provided valuable information to the ongoing FBI-led investigation following a historic trip to China. He stated, “President Trump has promised and delivered sweeping policies to quell the fentanyl epidemic in the United States. The FBI and our partners are implementing them 24/7, 365 days a year, across the country.”

In September, the Justice Department had already announced earlier indictments linked to Operation Boxcutter, which included three Americans, 22 Chinese nationals, and four additional Chinese pharmaceutical companies suspected of engaging in international drug trafficking.

Dominic S. Jealous II, the United States Attorney for the Southern District of Ohio, commented on the previous indictments from Operation Boxcutter, remarking, “Our indictment alleges that Chinese companies and affiliated foreign nationals knowingly and openly sold, delivered, and exported to the United States controlled substances and other compounds that they knew would be used by domestic drug dealers.” He further noted, “These deadly drug mixtures were then sold directly to our communities here in southern Ohio.”